Search results

Order by most recent / most popular / relevance

Results: 1-6 of 6

Ontario court confirms generic drug manufacturers not entitled to unjust enrichment

Torys LLP
-
Canada
-
January 22 2013

On January 15, 2013, the Ontario Superior Court of Justice (Ontario Court) granted a motion for partial summary judgment in Apotex Inc. v. Abbott

Health Canada’s guidance document on PM(NOC) Regulations now finalized

Torys LLP
-
Canada
-
April 4 2012

Health Canada has published an update to its guidance document on the application of the Patented Medicines (Notice of Compliance) Regulations

Federal Court of Canada grants data protection to an old medicinal ingredient

Torys LLP
-
Canada
-
February 14 2012

In a recent decision Celgene Inc. v. Canada (Minister of Health) the Federal Court of Canada declared that a drug containing a previously approved medicinal ingredient is nevertheless subject to data protection

Proposed amendment would exempt some generic submissions from Canada’s PM(NOC) regulations

Torys LLP
-
Canada
-
October 4 2011

Health Canada has released a proposed amendment to its guidance document Patented Medicines (Notice of Compliance) Regulations

Doing a deal with pharma

Torys LLP
-
Canada
-
August 4 2011

From the perspective of the biotech company, there are several legal and business issues to consider when doing a deal with big pharma

Innovative drugs sold under the special access programme can receive data protection in Canada

Torys LLP
-
Canada
-
May 18 2011

To benefit from data protection in Canada, a drug must meet the definition of "innovative drug" under the Food and Drug Regulations

Search results

Ontario court confirms generic drug manufacturers not entitled to unjust enrichment

Health Canada’s guidance document on PM(NOC) Regulations now finalized

Federal Court of Canada grants data protection to an old medicinal ingredient

Proposed amendment would exempt some generic submissions from Canada’s PM(NOC) regulations

Doing a deal with pharma

Innovative drugs sold under the special access programme can receive data protection in Canada

Current Search

Suggested Facets

Author

Workarea